Pfizer Inc.PFENYSE
Loading
Net Income ContractionContracting
Percentile Rank21
3Y CAGR-37.2%
5Y CAGR-3.2%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
-37.2%/yr
vs +29.5%/yr prior
5Y CAGR
-3.2%/yr
Recent deceleration
Acceleration
-66.7pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.77B | -3.1% |
| 2024 | $8.02B | +276.0% |
| 2023 | $2.13B | -93.2% |
| 2022 | $31.36B | +41.6% |
| 2021 | $22.15B | +141.8% |
| 2020 | $9.16B | -43.7% |
| 2019 | $16.27B | +45.9% |
| 2018 | $11.15B | -47.7% |
| 2017 | $21.30B | +195.3% |
| 2016 | $7.21B | - |